Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...
Synthio Labs, a clinical-grade voice AI company transforming how life sciences organisations engage clinicians and patients, ...
Assays are still pending for 80 holes from this year’s exploration campaign, of which 62 (representing 78% of the total pending) contain visible gold to the naked eye (VG-NE); see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback